Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers

Lignende værker

• Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
  af: Paquet, Tanya, et al.
  Udgivet: (2017)
• A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048
  af: McCarthy, James S, et al.
  Udgivet: (2020)
• Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics
  af: Ghidelli-Disse, Sonja, et al.
  Udgivet: (2014)
• A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers
  af: McCarthy, James S., et al.
  Udgivet: (2019)
• A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives
  af: Dambuza, Ntokozo, et al.
  Udgivet: (2015)